Member Info for Chrisatrdg

Hi Jimmy00 - The next hour could be interesting as expectations are that the SP may go up further next week & people may wish to Buy more at these current prices before then.

Now at 21.74% increase thats better 50p next ? I am now showing as a 'Strong Buy'.Well done Summit.

Very good news today well done Summit hopefully this will stop the SP downward spiral & for it to start to move up.Currently good price to Buy at.

Discuva: Leading The Global Medical Search For New Lifesaving Antibiotics - 6TH July 2015
(NB: The person featured in the film David Williams was the founder of Discuva & following its acquisition by Summit no longer on the payroll but it makes for good background 'reading' & just shows what Summit have acquired - all very good from what I can see) https://www.youtube.com/watch?v=kkCnN5IsFrA

Below is the link to slides at yesterdays presentation:

https://seekingalpha.com/article/4197239-summit-therapeutics-smmt-presents-canaccord-genuity-38th-annual-growth-conference-slideshow?dr=1

Correction - 'of this $2.9m 3 months to 30.06.18 not 31.03.18)

Serepta SEC sch out 6 months 30.06.18 & shows on cost share with Summit as being per below of which $2.6 m shown as accrued costs as at 30.06.18:
$6.1 million increase in collaboration cost sharing with Summit on its Utrophin platform( 6 months to 30.06.18) (of this $2.9m 3 months to 31.03.18).https://seekingalpha.com/filing/4129744

Edit: Extract from call relating to Serepta's results:
'As of January 1, 2018, we started to share 45% of the costs related to Summit’s research and development expenses for the utrophin program. Due to the termination of Summit’s utrophin program during the second quarter of 2018, we expect this expense to significantly decline over the upcoming quarters.'
PS I can find no more mention of Summit on reading the script one way of burying bad news.

Listened with interest today & Glyn once again sounding enthusiastic about the various pipe lines but not sure we learnt anything new

Great RNS very detailed & shows great confidence in the potential success of the project.

Summit's ridinilazole beats vancomycin in C. diff study
https://seekingalpha.com/news/3377794-summits-ridinilazole-beats-vancomycin-c-diff-study

Detailed below is the link showing as at 24th July 2018 current Director shareholdings & those holding 3% or more & ties in to the share numbers detailed today.Good to see Legal & Generals holding at 8.5%

http://www.infrastrata.co.uk/index.php?option=com_content&task=view&id=75&Itemid=59

No deal announced yet just a rumour.

Lets hope we do not get an RNS warning to correct the rumours they are usually the 'kiss of death'.

Think of 5p if no dilution.

We received an update in June by RNS indicating a better than previously expected results for Y/E 30.06.18 so would expect results shortly hopefully this will give some momentum back into the current SP.Ever hopeful.

After many years of having invested in INFA I have finally broken even today & hopefully INFA will start to show a return on my investment.The board seems in the main very positive & I look forward to further advancements in the project.At one time there were only 3 or 4 of us posting on this board some not even interested in the project.Onwards & upwards.I feel I can now say it is a 'Strong Buy'.

Are institutions Buying in?

Hi stew200 I averaged down in the week of the DMD RNS by increasing my shares by 1/3rd & is now reflected in the figures I quoted earlier but no more funds left.It is now a matter of sitting on the shares for the next year or two.Regards.

wildbunch I so agree with you there is much we need to know about & the market too before we get to £0.40 & for me with an average of £0.96 on 50,000 shares there is a long way to go before I can even think of getting my money back let alone make a profit.I expect to be waiting 1 to 2 years to break even which has totally screwed things for me in my retirement.I just hope my current paper loss of £32k will just be a paper loss.However for new comers the current SP is a bargain so I am posting 'A Buy'.

Well said dawski37 currently INFA a better bet than some of my bio tech shares.Onwards & upwards.